News

Article

Rheumatoid Arthritis Quiz: Biosimilars in RA

Author(s):

Ingrid Torjesen

Biosimilars to several recognized biologic rheumatoid arthritis treatments are now approved for use in the United States. Test your knowledge with this quiz.

As of October 1, 2023, how many biosimilars had been approved for use in the United States?


Related Videos
Duloxetine for Patients with COPD Suffering from Comorbid Depression
Enhancing Standards for Ethical Responsibilities within Clinical Research
Jennifer Flemming, MD | Credit: AASLD
Related Content
Orrin M. Troum, MD, Division of Rheumatology, University of Southern California Keck School of Medicine and Providence Saint John’s Health Center
January 21st 2025

Pegloticase Does Not Increase Risk of CV/TE Events in People With Gout

Victoria Johnson
Default thumbnail for The Medical Sisterhood podcast
January 16th 2025

Medical Sisterhood: Polished and Powerful—Women Leading the Charge in Advocacy

Mona Shahriari, MD, FAAD Shadi Kourosh, MD, MPH
Kidneys | Credit: Fotolia
January 20th 2025

Study Describes Clinical Features, Prognosis of Patients with IgAN, Nephrotic Syndrome

Abigail Brooks, MA
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes | Image Credit: HCPLive
January 16th 2025

Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Technology

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
FDA Accepts Plozasiran NDA for Familial Chylomicronemia Syndrome | Image Credit: US Food and Drug Administration
January 20th 2025

FDA Accepts Plozasiran NDA for Familial Chylomicronemia Syndrome

Connor Iapoce
Stephen Schworer, MD, PhD | Credit: American Lung Association
January 20th 2025

Small Airway Mucus Plugging in Severe Asthma: Insights and Implications

Stephen Schworer, MD, PhD
© 2025 MJH Life Sciences

All rights reserved.